US Centers for Medicare and Medicaid Services: Eleven medical supply companies suspected of defrauding more than $3.4 billion are prohibited from receiving future payments from Part C and Part D of the Federal Medicare Advantage Plan.

US Centers for Medicare and Medicaid Services: Eleven medical supply companies suspected of defrauding more than $3.4 billion are prohibited from receiving future payments from Part C and Part D of the Federal Medicare Advantage Plan.